|

Pemetrexed 500 mg/m2 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Yang Hong1

Indications

  • Stage IIIC Non-Small Cell Lung Cancer1
  • Stage IIIB Non-small Cell Lung Cancer1
  • Locally Advanced Non-Small Cell Lung Cancer1
  • Lung Cancer1
  • Cancer1

Other1 trial

Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.